CELC Stock Analysis: Buy, Sell, or Hold?

CELC - Celcuity Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$89.93
2.17 (2.47%) ▲
5d: +1.56%
30d: -35.92%
90d: -15.19%
HOLD
MODERATE Confidence
Protect Your CELC Gains
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Smart Money Distribution

None View Scanner →

Strength: 4.7/10

Get Alerted When CELC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: CELC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$25.92
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$16.10
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CELC is currently trading at $89.93, which is considered oversold relative to its 30-day fair value range of $90.22 to $134.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 121.5) compared to its historical average (146.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CELC is showing sideways momentum. Immediate support is located at $82.55, while resistance sits at $95.97.

Market Sentiment: CELC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $161.09 (+79.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $90.22 - $134.37
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Protect Your Profits

Holding CELC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 79.1% below Wall St target ($161.09)

Trading Range Analysis

30-Day Trading Range $90.22 - $134.37
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $82.55
Resistance Level $95.97
Current Trend Sideways
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) 121.53
Wall Street Target $161.09 (+79.1%)
Valuation Discount vs History -6.1% cheaper
PE vs Historical 121.5 vs 146.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -6.1% (market-implied from PE analysis)
1-Year Target $84.44 (-6%)
2-Year Target $79.29 (-12%)
3-Year Target $74.46 (-17%)
3-Yr Target (if PE normalizes) (PE: 122→147) $90.00 (+0%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 121.5 to 146.9
Stabilization Target: $108.71 (+20.9%)
PE Expansion Potential: +20.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 3:48 AM ET
Data refreshes hourly during market hours. Next update: 4:48 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller SELL 3000 shares 2026-03-31
David Dalvey SELL 20000 shares 2026-01-27

Unlock Insider Activity

See real-time buying/selling by company executives for CELC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 53 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 64 BUY
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 56 HOLD
DYN
Dyne Therapeutics Inc
STRONG BUY
14 analysts
$38 60 BUY
DNTH
Dianthus Therapeutics In…
STRONG BUY
12 analysts
$128 57 HOLD

Advanced CELC Option Strategies

Professional options setups generated by AI based on today's CELC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CELC

CELC Technical Chart CELC Price Prediction CELC Earnings Date CELC Investment Advisor CELC Fair Price Analyzer CELC Options Advisor CELC Options Chain CELC Options Analysis CELC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals